Description
Bioconjugation technology has caused the birth of billion-dollar industries serving research, diagnostics, and therapeutic markets. A significant portion of all biological assays, including clinical testing, is now done using unique bioconjugates that have the ability to interact with particular analytes in solutions, cells, or tissues. Crosslinking and modifying agents can be applied to alter the native state and function of peptides and proteins. Through careful modification or conjugation strategies, the structure and function of peptides and proteins can be investigated, active site conformation discovered, or receptor-ligand interactions revealed.